Radiographic staging and bronchoalveolar lavage cell counts in sarcoidosis;Estadios radiológicos y lavado broncoalveolar en la sarcoidosis

Archivos de Bronconeumologia

Volumn 41, Issue 8, 2005, Pages 425-429

  Vidal Serrano, S ^a,c   Martin Juan J ^a   Gomez Izquierdo L ^a   Sanchez Rodriguez I ^b   Rodriguez Becerra E ^a   Rodriguez Panadero F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^c NONE   (Spain)

Author keywords

Bronchoalveolar lavage; Radiographic stages; Sarcoidosis

Indexed keywords

ADULT; AGE; ARTICLE; CELL COUNT; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GENDER; GRANULOMATOUS INFLAMMATION; HUMAN; LUNG LAVAGE; MALE; RESPIRATORY FUNCTION; SARCOIDOSIS; SMOKING HABIT; THORAX RADIOGRAPHY;

EID: 25144434837     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13077953     Document Type: Article

References (23)

1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224-34.
2. Siltzbach LE. Sarcoidosis: clinical features and management. Med Clin North Am. 1967;51:483-502.
3. Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology. 1994;191:675-80.
4. Keogh BA, Hunninghake GW, Line BR, Crystal RG. The alveolitis of pulmonary sarcoidosis: evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis. 1983;128:256-65.
5. Foley NM, Coral AP, Tung K, Hudspith BN, James DG, McJohnson N. Bronchoalveolar lavage cell counts as predictor of short term outcome in pulmonary sarcoidosis. Thorax. 1989;44: 472-38.
6. Buchalter S, App W, Jackson L, Chandler D, Jackson R, Fulmer J. Bronchoalveolar lavage cell analysis in sarcoidosis: a comparison of lymphocyte counts and clinical course. Ann N Y Acad Sci. 1986;465:678-84.
7. Costabel U, Bross KJ, Guzman J, Nilles A, Rühle KH, Matiz H. Predictive value broncoalveolar T cell subsets for the course of pulmonary sarcoidosis. Ann N Y Acad Sci. 1986;465:418-26.
8. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Müller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of SIL-2R are prognostic markers. Am J Respir Crit Care Med. 1997;156:1586-92.
9. Ziegenhagen MW, Rothe ME, Schlaak M, Müller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J. 2003;21:407-13.
10. Xaubet A, Ancochea J, Blanquer R, Montera C, Morell F, Rodriguez Becerra E, et al. Diagnóstico y tratamiento de las enfermedades pulmonares intersticiales difusas. Arch Bronconeumol. 2003;39:580-600.
11. Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, et al. Outcome of the treatment of sarcoidosis. Am J Respir Crit Care Med. 1994;149:893-8.
12. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85: 751-8.
13. Sanchis J, Casán P, Castillo J, Gonzalez N, Palenciano L, Roca J. Normativa para la práctica de la espirometría forzada. Arch Bronconeumol. 1989;25:132-42.
14. Castella J, Ancochea J, Llorente L, Puzo C, Sanchís J, Sueiro A, et al. Normativa SEPAR: lavado broncoalveolar. Arch Bronconeumol. 1997;33:515-26.
15. Martín Juan J, Valenzuela Mateos F, Soto Campos G, Segado Soriano A, Rodríguez Panadero F, Gómez Castillo J. Estudio de calidad y selección de muestras de lavado broncoalveolar (LBA) en neumopatías difusas. Arch Bronconeumol. 1996;32:332-40.
16. American Thoracic Society. Broncoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis. 1990;141 Suppl 5:167-202.
17. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-55.
18. Tahanovich AD, Katovich IL, Baradzina HL. Evaluation of bronchoalveolar lavage fluid phospholipids and cytokine release by alveolar macrophages as prognostic markers in sarcoidosis. Respiration. 2003;376-81.
19. Laviolette M, La Forge J, Tennina S, Boulet L-P. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis. Chest. 1991;100:380-4.
20. Drent M, Jacobs JA, De Vries J, Lamers RJ, Liera IH, Wouters EF. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Resp J. 1999;13:1338-44.
21. Lin YH, Haslam PL, Turner-Warwick M. Chronic pulmonary sarcoidosis: relationship between lung lavage cell counts, chest radiograph, and results of standard lung function tests. Thorax. 1985;40:501-7.
22. Ward K, O'Connor C, Odlum C, Fitzgerald MX. Prognostic value of bronchoalveolar lavage in sarcoidosis: the clinical influence of disease presentation. Thorax. 1989;44:6-12.
23. Welker L, Jörres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J. 2004;24:1000-6.